Literature DB >> 7320120

Plasma catecholamines in hypertension and pheochromocytoma determined using ion-pair reversed-phase chromatography with amperometric detection: investigation of the separation mechanism and clinical methodology.

A M Krstulović, S W Dziedzic, L Bertani-Dziedzic, D E DiRico.   

Abstract

The retention behavior of catecholamines (CAs) in ion-pair reversed-phase chromatography is examined. From the effects of pH, ionic strength and a secondary ion-pairing reagent (citric acid), under our chromatographic conditions, the retention behavior can be explained by assuming a mixed ion-exchange mechanism with octyl sulfate and citrate, on the column and in the mobile phase, respectively. The developed separation method was applied to the analysis of CAs in plasma samples purified by alumina adsorption and detected amperometrically. This method provides the basis for the determination of the short-term magnitude of CA response to physical and physiological interventions, as well as the baseline CA levels in essential hypertension and pheochromocytoma. The results seen for norepinephrine and epinephrine are consistent with eh funcitonal roles of these CAs as hormones or peripheral transmitters.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7320120     DOI: 10.1016/s0021-9673(00)88103-0

Source DB:  PubMed          Journal:  J Chromatogr


  9 in total

1.  A comparison of the haemodynamic and hormonal effects of low and conventional dose cyclopenthiazide in normal volunteers.

Authors:  G E McVeigh; M McMaster; T Linton; E Whitehead; G D Johnston
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Haemodynamic and pharmacokinetic evaluation of alfuzosin in man. A dose ranging study and comparison with prazosin.

Authors:  M G Scott; A H Deering; M T McMahon; D W Harron; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  The effect of chronic captopril therapy on adrenergic receptors, plasma noradrenaline and the vascular responses to infused noradrenaline.

Authors:  G B Kondowe; S Copeland; A P Passmore; W J Leahey; G D Johnston
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Plasma and tissue chromogranin in patients with adrenocortical adenomas.

Authors:  G P Bernini; A Moretti; M Borgioli; M Bardini; P Miccoli; P Berti; F Basolo; P Faviana; R Birindelli; A Salvetti
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

5.  Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.

Authors:  D P Nicholls; J McNeill; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

6.  Differential blockade of alpha-adrenoceptors by indoramin.

Authors:  D P Nicholls; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

7.  Pheochromocytoma in the horse and measurement of norepinephrine levels in horses.

Authors:  J V Yovich; F D Horney; G E Hardee
Journal:  Can Vet J       Date:  1984-01       Impact factor: 1.008

8.  Comparison of the acute renal and peripheral vascular responses to frusemide and bumetanide at low and high dose.

Authors:  A P Passmore; E M Whitehead; G D Johnston
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

9.  A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.

Authors:  G P Bernini; A Moretti; M Ferdeghini; S Ricci; C Letizia; E D'Erasmo; G F Argenio; A Salvetti
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.